{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-017222","form_type":"8-K","ticker":"MAIA","cik":"0001878313","company_name":"MAIA Biotechnology, Inc.","filed_at":"2025-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.951406+00:00","generated_at":"2026-05-17T04:29:17.697102+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"MAIA Biotechnology to hold up to 90% of liquid assets in Bitcoin, Ethereum, and USDC","bullets":["Board authorized up to 90% of liquid assets to be held in cryptocurrencies: BTC, ETH, and USDC.","Initial tokens: Bitcoin (BTC), Ethereum (ETH), and USD Coin (USDC).","Company intends to form a Digital Assets Advisory Board to support strategy.","CEO Vlad Vitoc cites disciplined approach targeting highest-quality tokens for strong returns."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-017222","json":"https://secwatch.observer/filing/0001493152-25-017222.json","markdown":"https://secwatch.observer/filing/0001493152-25-017222.md","text":"https://secwatch.observer/filing/0001493152-25-017222.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1878313/000149315225017222/0001493152-25-017222-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1878313/000149315225017222/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:29:17.697102+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}